Prevalence of micronuclei in exfoliated uterine cervical cells from patients with risk factors for cervical cancer
Keywords:
Cells, Cervix uteri, Risk factors, Neoplasms, Micronucleus testAbstract
CONTEXT AND OBJECTIVE: Pap smears are the most common and inexpensive screening method for cervical cancer. We analyzed micronucleus prevalence in exfoliated cervical mucosa cells, to investigate associations between increased numbers of micronuclei and risk factors for cervical cancer. DESIGN AND SETTING: Analytical cross-sectional study, at Instituto de Pesquisa em Oncologia (IPON). METHODS: Exfoliated cervical cells were obtained from 101 patients between September 2004 and November 2005. Patients’ ages, habits (passive or active smoking, alcoholism and numbers of sexual partners), age at fi rst sexual intercourse, contraceptive methods used, histories of sexually transmitted diseases, use of hormone replacement therapy, numbers of pregnancies and abortions, infl ammatory cytology and cervical intraepithelial neoplasia (CIN) were obtained. Cells were collected using Ayre spatulas, transferred to vials containing 0.9% saline solution for micronucleus tests and analyzed at 1000x magnifi cation. The number of micronuclei in 1,000 epithelial cells per patient sample was counted. RESULTS: Comparisons between groups with active (7.9 ± 7.8) and passive (7.2 ± 10.6) smoking versus no smoking (3.7 ± 5.1); with/ without alcoholism (7.8 ± 1.4 and 6.9 ± 10.1); with/without infl ammatory cytology (10.7 ± 10.5 and 1.3 ± 1.7); and with CIN I, II and III and no CIN (respectively 4.3 ± 4.3, 10.6 ± 5.3, 22.7 ± 11.9 and 1.3 ± 1.4) found elevated micronucleus prevalence (P < 0.05). CONCLUSIONS: We concluded that the prevalence of micronuclei in exfoliated uterine cervical cells was greater in patients with one or more risk factors for uterine cervical cancer than in patients without risk factors.
Downloads
References
Waggoner SE. Cervical cancer. Lancet. 2003;361(9376):2217- 25.
Valdespino VM, Valdespino VE. Cervical cancer screening: state of the art. Curr Opin Obstet Gynecol. 2006;18(1):35-40.
Gonsebatt ME, Guzmán P, Blas J. Cytogenetic and cytotoxic damage in exfoliated cells as indicators of effects in humans. In: Biomonitors and biomarkers as indicators of environmental change. Butterworth F, Gunatilaka A, Gonsebatt ME, editors. New York: Kluwer/Plenum Press; 2000. p. 317-32.
Guzmán P, Sotelo-Regil RC, Mohar A, Gonsebatt ME. Posi- tive correlation between the frequency of micronucleated cells and dysplasia in Papanicolaou smears. Environ Mol Mutagen. 2003;41(5):339-43.
Giannoudis A, Evans MF, Southern SA, Herrington CS. Basal keratinocyte tetrasomy in low-grade squamous intra- epithelial lesions of the cervix is restricted to high and interme- diate risk HPV infection but is not type-specific. Br J Cancer. 2000;82(2):424-8.
Loeb LA. A mutator phenotype in cancer. Cancer Res. 2001;61(8):3230-9.
Gisselsson D. Refined characterisation of chromosome aber- rations in tumours by multicolour banding and electronic mapping resources. Methods Cell Sci. 2001;23(1-3):23-8.
Masumoto N, Fujii T, Ishikawa M, et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients. Gynecol Oncol. 2004;94(2):509-14.
Oliveira LH, Rosa ML, Pereira CR, et al. Human papillomavirus status and cervical abnormalities in women from public and private health care in Rio de Janeiro State, Brazil. Rev Inst Med Trop Sao Paulo. 2006;48(5):279-85.
Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol. 1988;158(4):910-3.
Simons AM, Philips DH, Coleman DV. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ. 1993;306(6890):1444-8.
Weiderpass E, Ye W, Tamimi R, et al. Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva. Cancer Epidemiol Biomarkers Prev. 2001;10(8):899-901.
Olaharskil AJ, Sotelo R, Solorza-Luna G, et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis. 2006;27(2):337-43.
Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus Project--An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res. 1999;428(1-2):271-83.
Stafl A, Wilbanks GD. An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet Gynecol. 1991;77(2):313-4.
Carrano AV, Natarajan AT. International Commission for Protection Against Environmental Mutagens and Carcinogens.
ICPEMC publication no. 14. Considerations for popula- tion monitoring using cytogenetic techniques. Mutat Res.
;204(3):379-406.
Gupta PK. Microbiology, inflammation, and viral infections. In: Bibbo M, editor. Comprehensive cytopathology. Philadelphia: WB Saunders Company; 1997. p. 125-60.
Solomon D. The Bethesda system for cervicovaginal cytopa- thology. In: Bibbo M, editor. Comprehensive Cytopathology. Philadelphia: WB Saunders Company; 1997. p. 93-100.
Adad SJ, de Lima RV, Sawan ZT, et al. Frequency of Trichomo- nas vaginalis, Candida sp and Gardnerella vaginalis in cervical- vaginal smears in four different decades. Sao Paulo Med J. 2001;119(6):200-5.
Schneider A, Meinhardt G, De-Villiers EM, Gissmann L. Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV-DNA hybridization studies. Diagn Cytopathol. 1987;3(3):250-5.
Mangan SA, Legano LA, Rosen CM, et al. Increased prevalence of abnormal Papanicolaou smears in urban adolescents. Arch Pediatr Adolesc Med. 1997;151(5):481-4.
Park JS, Rhyu JW, Kim CJ, et al. Neoplastic change of squamo- columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice. Gynecol Oncol. 2003;89(3):360-8.
Shapiro S, Rosenberg L, Hoffman M, et al. Risk of invasive cancer of the cervix in relation to the use injectable proges- togen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Cancer Causes Control. 2003;14(5):485-95.
Dziubinska-Parol I, Gasowska U, Rzymowska J, Kwasniewska A. Wplyw fizjologicznych stezen 17 beta-estradiolu na ek- spresje in vitro genu E6 wirusa brodawczaka ludzkiego typ18. [Influence of physiologic 17 beta-estradiol concentrations on gene E6 expression in HPV type 18 in vitro]. Ginekol Pol. 2003;74(9):710-3.
Shields TS, Falk RT, Herrero R, et al. A case-control study of endogenous hormones and cervical cancer. Br J Cancer. 2004;90(1):146-52.
Cerqueira EM, Santoro CL, Donozo NF, et al. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol. 1998;42(3):639-49.
Matsumoto K, Yasugi T, Oki A, et al. Are smoking and Chlamydia infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies. Br J Cancer. 2003;89(5):831-3.
Tay SK, Tay KJ. Passive cigarette smoking is a risk factor in cervical neoplasia. Gynecol Oncol. 2004;93(1):116-20.
Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E. Smok- ing and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol. 1988;158(4):910-3.
Johnson JD, Houchens D, Kluwe WM, Craig DK, Fisher GL. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol. 1990;20(5):369-95.
Poppe WA, Drijkoningen M, Ide PS, Lauweryns JM, Van Assche FA. Langerhans’ cells and L1 antigen expression in normal and abnormal squamous epithelium of the cervical transformation zone. Gynecol Obstet Invest. 1996;41(3):207-13.
Nishimura M, Furumoto H, Kato T, Kamada M, Aono T. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer. Gynecol Oncol. 2000;79(2):201-6.
Fischer N. Chlamydia trachomatis infection in cervical intraepi- thelial neoplasia and invasive carcinoma. Eur J Gynaecol Oncol. 2002;23(3):247-50.
Smith JS, Muñoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis. 2002;185(3):324-31.
Murta EF, Souza MA, Araújo Júnior E, Adad SJ. Incidence of Gardnerella vaginalis, Candida sp and human papilloma virus in cytological smears. Sao Paulo Med J. 2000;118(4):105-8.
da Silva CS, Adad SJ, Hazarabedian de Souza MA, Macêdo Barcelos AC, Sarreta Terra AP, Murta EF. Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. Gynecol Obstet Invest. 2004;58(4):189-93.
Barcelos AC, Adad SJ, Michelin MA, Murta EF. Atypical squamous cells of undetermined significance: analysis of mi- crobiology, cytological criteria and clinical conduct. Tumori. 2006;92(3):213-8.
Deluca GD, Lucero RH, Martin de Civetta MT, et al. Human papillomavirus genotypes in women with cervical cytological abnormalities from an area with high incidence of cervical cancer. Rev Inst Med Trop Sao Paulo. 2004;46(1);9-12.
Leal-Garza CH, Cerda-Flores RM, Leal-Elizondo E, Cortés-Gutiérrez EI. Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat Res. 2002;515(1-2):57-62.
Paz-y-Miño C, Ocampo L, Narváez R, Narváez L. Chromosome fragility in lymphocytes of women with cervical uterine lesions produced by human papillomavirus. Cancer Genet Cytogenet. 1992;59(2):173-6.
Kamboj M, Mahajan S. Micronucleus--an upcoming marker of genotoxic damage. Clin Oral Investig. 2007;11(2):121-6.
Lou J, He J, Zheng W, et al. Investigating the genetic instabil- ity in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay. Mutat Res. 2007;617(1-2):104-10.
Bonassi S, Znaor A, Ceppi M, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 2007;28(3):625-31.
Murta EF, Resende AV, Souza MA, Adad SJ, Salum R. Importance of surgical margins in conization for cervical intraepithelial neoplasia grade III. Arch Gynecol Obstet. 1999;263(1-2):42-4.
Maluf PJ, Adad SJ, Murta EF. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses. Tumori. 2004;90(5):473-7.
Terra AP, Murta EF, Maluf PJ, Caballero OL, Brait M, Adad SJ. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III. Tumori. 2007;93(6):572-9.
